Clinical Trial: Pimecrolimus Cream 1% in Adult Patients With Perioral Dermatitis

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Pimecrolimus Cream 1% in Adult Patients With Perioral Dermatitis

Brief Summary:

An evaluation of the safety and efficacy of the calcineurin inhibitor, pimecrolimus cream 1%, in adult patients with perioral dermatitis.

This study is not enrolling patients in the United States.


Detailed Summary:
Sponsor: Novartis

Current Primary Outcome: Reduction of the Perioral Dermatitis Severity Index

Original Primary Outcome:

Current Secondary Outcome:

  • Time to disease recurrence
  • Response rates
  • Patient's quality of life assessment
  • Patient's disease severity assessment


Original Secondary Outcome:

Information By: Novartis

Dates:
Date Received: October 3, 2005
Date Started: September 2005
Date Completion:
Last Updated: January 15, 2008
Last Verified: January 2008